| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2161079 | Radiotherapy and Oncology | 2007 | 7 Pages |
Abstract
In younger patients a boost dose resulted in a greater absolute reduction of local failure. The relative risk reduction was however similar for all ages. Applying a treatment policy with a threshold-age of 60 would result in 0.6% increase in local failure in the total study population, while sparing the boost to 1/3 of the patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ninja Antonini, Heather Jones, Jean Claude Horiot, Philip Poortmans, Henk Struikmans, Walter Van den Bogaert, Isabelle Barillot, Alain Fourquet, Jos Jager, Willem Hoogenraad, Laurence Collette, Marianne Pierart, Guus Hart, Harry Bartelink,